This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase 2, Multicenter, Single-arm Study of Moxetu...
Clinical trial

A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects with Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin

Read time: 1 mins
Last updated:18th Mar 2013
Assess the efficacy defined as Composite Complete Response (CRc)
Category Value
Study start date 2013-03-18

View full details